Australia markets closed

Navamedic ASA (0FDB.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
36.50-0.69 (-1.86%)
At close: 06:07PM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-5.34%
S&P500 52-week change 322.38%
52-week high 341.30
52-week low 30.00
50-day moving average 338.92
200-day moving average 338.92

Share statistics

Avg vol (3-month) 3134
Avg vol (10-day) 3134
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 141.94%
% held by institutions 123.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.74%
Operating margin (ttm)2.81%

Management effectiveness

Return on assets (ttm)5.46%
Return on equity (ttm)1.76%

Income statement

Revenue (ttm)512M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)8.10%
Gross profit (ttm)N/A
EBITDA 51.57M
Net income avi to common (ttm)3.81M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.04M
Total cash per share (mrq)N/A
Total debt (mrq)152.89M
Total debt/equity (mrq)68.59%
Current ratio (mrq)1.11
Book value per share (mrq)12.17

Cash flow statement

Operating cash flow (ttm)2.18M
Levered free cash flow (ttm)67.73M